Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

489 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Establishment of a Radiogenomics Consortium.
West C, Rosenstein BS, Alsner J, Azria D, Barnett G, Begg A, Bentzen S, Burnet N, Chang-Claude J, Chuang E, Coles C, De Ruyck K, De Ruysscher D, Dunning A, Elliott R, Fachal L, Hall J, Haustermans K, Herskind C, Hoelscher T, Imai T, Iwakawa M, Jones D, Kulich C; EQUAL-ESTRO; Langendijk JH, O'Neils P, Ozsahin M, Parliament M, Polanski A, Rosenstein B, Seminara D, Symonds P, Talbot C, Thierens H, Vega A, West C, Yarnold J. West C, et al. Among authors: de ruyck k, de ruysscher d. Int J Radiat Oncol Biol Phys. 2010 Apr;76(5):1295-6. doi: 10.1016/j.ijrobp.2009.12.017. Int J Radiat Oncol Biol Phys. 2010. PMID: 20338472 No abstract available.
Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non-small-cell lung cancer: a modeling study.
van Der Wel A, Nijsten S, Hochstenbag M, Lamers R, Boersma L, Wanders R, Lutgens L, Zimny M, Bentzen SM, Wouters B, Lambin P, De Ruysscher D. van Der Wel A, et al. Among authors: de ruysscher d. Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):649-55. doi: 10.1016/j.ijrobp.2004.06.205. Int J Radiat Oncol Biol Phys. 2005. PMID: 15708242
PET-CT-based auto-contouring in non-small-cell lung cancer correlates with pathology and reduces interobserver variability in the delineation of the primary tumor and involved nodal volumes.
van Baardwijk A, Bosmans G, Boersma L, Buijsen J, Wanders S, Hochstenbag M, van Suylen RJ, Dekker A, Dehing-Oberije C, Houben R, Bentzen SM, van Kroonenburgh M, Lambin P, De Ruysscher D. van Baardwijk A, et al. Among authors: de ruysscher d. Int J Radiat Oncol Biol Phys. 2007 Jul 1;68(3):771-8. doi: 10.1016/j.ijrobp.2006.12.067. Epub 2007 Mar 29. Int J Radiat Oncol Biol Phys. 2007. PMID: 17398018
HI-CHART: a phase I/II study on the feasibility of high-dose continuous hyperfractionated accelerated radiotherapy in patients with inoperable non-small-cell lung cancer.
De Ruysscher D, Wanders R, van Haren E, Hochstenbag M, Geraedts W, Pitz C, Simons J, Boersma L, Verschueren T, Minken A, Bentzen SM, Lambin P. De Ruysscher D, et al. Int J Radiat Oncol Biol Phys. 2008 May 1;71(1):132-8. doi: 10.1016/j.ijrobp.2007.09.048. Epub 2007 Nov 26. Int J Radiat Oncol Biol Phys. 2008. PMID: 18037581 Clinical Trial.
Radiation dose prescription for non-small-cell lung cancer according to normal tissue dose constraints: an in silico clinical trial.
van Baardwijk A, Bosmans G, Bentzen SM, Boersma L, Dekker A, Wanders R, Wouters BG, Lambin P, De Ruysscher D. van Baardwijk A, et al. Among authors: de ruysscher d. Int J Radiat Oncol Biol Phys. 2008 Jul 15;71(4):1103-10. doi: 10.1016/j.ijrobp.2007.11.028. Epub 2008 Feb 6. Int J Radiat Oncol Biol Phys. 2008. PMID: 18258382 Clinical Trial.
First report on the patient database for the identification of the genetic pathways involved in patients over-reacting to radiotherapy: GENEPI-II.
De Ruysscher D, Severin D, Barnes E, Baumann M, Bristow R, Grégoire V, Hölscher T, Veninga T, Polański A, van Veen EB, Verfaillie C, Heeren G, Damaraju S, Just U, Haustermans K. De Ruysscher D, et al. Radiother Oncol. 2010 Oct;97(1):36-9. doi: 10.1016/j.radonc.2010.03.012. Epub 2010 Mar 24. Radiother Oncol. 2010. PMID: 20338650
Development of a multicomponent prediction model for acute esophagitis in lung cancer patients receiving chemoradiotherapy.
De Ruyck K, Sabbe N, Oberije C, Vandecasteele K, Thas O, De Ruysscher D, Lambin P, Van Meerbeeck J, De Neve W, Thierens H. De Ruyck K, et al. Among authors: de neve w, de ruysscher d. Int J Radiat Oncol Biol Phys. 2011 Oct 1;81(2):537-44. doi: 10.1016/j.ijrobp.2011.03.012. Epub 2011 May 24. Int J Radiat Oncol Biol Phys. 2011. PMID: 21605946
A 2-stage genome-wide association study to identify single nucleotide polymorphisms associated with development of erectile dysfunction following radiation therapy for prostate cancer.
Kerns SL, Stock R, Stone N, Buckstein M, Shao Y, Campbell C, Rath L, De Ruysscher D, Lammering G, Hixson R, Cesaretti J, Terk M, Ostrer H, Rosenstein BS. Kerns SL, et al. Among authors: de ruysscher d. Int J Radiat Oncol Biol Phys. 2013 Jan 1;85(1):e21-8. doi: 10.1016/j.ijrobp.2012.08.003. Epub 2012 Sep 26. Int J Radiat Oncol Biol Phys. 2013. PMID: 23021708 Free PMC article. Clinical Trial.
No association between TGF-β1 polymorphisms and radiation-induced lung toxicity in a European cohort of lung cancer patients.
Voets AM, Oberije C, Struijk RB, Reymen B, De Ruyck K, Thierens H, Vandecasteele K, De Neve W, Houben R, De Ruysscher D, Smeets HJ, Lambin P. Voets AM, et al. Among authors: de ruyck k, de neve w, de ruysscher d. Radiother Oncol. 2012 Dec;105(3):296-8. doi: 10.1016/j.radonc.2012.09.016. Epub 2012 Nov 3. Radiother Oncol. 2012. PMID: 23127773
489 results